BioGx Lands CE Mark for Four Infectious Disease Tests

Feb

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Feb

Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Menu

BioGx Lands CE Mark for Four Infectious Disease Tests

To read the full story....

Breaking News

Biden Unveils Economic Plan to Provide $50B for COVID-19 Testing Expansion

Report Details COVID-19 Testing Within Federal Government

In Brief This Week: Yourgene Health, Deep Lens, Canexia Health, and More

DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech

FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

What's Popular?

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

FDA Issues Alert About Potential False Negative Test Results From SARS-CoV-2 Mutations

Sponsorships